Fair value · MULTI-UNITS LUXEMBOURG - Lyxor Commodities Refinitiv/CoreCommodity CRB TR UCITS ETF (CRBL.L) · updated 2026-09-12
These methods need positive earnings and cash flow from the company’s filed annual statements. The detailed valuation tools below still work with whatever has been filed.
At least two methods need a usable value to draw a range with these inputs.
No preset range for this company yet.
The two ranges are identical because every input sits on a preset.
We don’t tell you what CRBL.L is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has CRBL.L’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.
Discounted cash flow
N/A
Insufficient cash flow data
Preset inputs — revenue-driven DCF from the latest filing
Implied by today’s price
No free-cash-flow baseline in the filings yet.
Not solvable from the price — No free-cash-flow baseline in the filings yet. Showing preset inputs.
This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what CRBL.L has actually filed, and the AI chat will reason it through with you.
Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.
Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.
How long stage-1 growth lasts.
Slower growth after stage 1, before the terminal phase.
Growth forever after the two stages. Above ~3% is rarely justified.
The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.
Inputs from the filing
Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for CRBL.L